Inari Medical Inc expected to post a loss of 23 cents a share - Earnings Preview

Inari Medical

02/05/2023 03:06

* Inari Medical Inc  NARI.OQ   NARI.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 3. 
    * The Irvine California-based  company is expected to report
 a
27.1% increase in revenue to $110.289 million from $86.75
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Inari Medical Inc
is for
a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inari
Medical Inc
is $95.5​, above​ its last closing price of $63.82. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.17       -0.17      -0.11     Beat    35.8
 Sep. 30 2022  -0.26       -0.25      -0.19     Beat    25.1
 Jun. 30 2022  -0.23       -0.23      -0.19     Beat    17.4​
 Mar. 31 2022  -0.09       -0.09      -0.06     Beat    34.5
 ​​Dec.        0.06        0.03       0.02      Missed  -23.1
 31 2021                                                
 Sep. 30 2021  -0.21       -0.11      -0.06     Beat    45.5​
 Jun. 30 2021  0.09        0.08       0.07      Missed  -14.3
 Mar. 31 2021  0.07        0.05       0.13      Beat    151.6
 This summary was machine generated May 2 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated